Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03711890 · ClinicalTrials.gov registry record · NA
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT03711890 is a NA study that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 75 participants.
The verdict
NCT03711890, a NA study, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.
Interventions
- PROCEDURE Therapeutic Conventional Surgery
- PROCEDURE Optical Coherence Tomography
- DIAGNOSTIC_TEST Laboratory Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-03-26 |
| Est. Completion | 2026-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03711890
The ClinicalTrials.gov registry entry for NCT03711890 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Therapeutic Conventional Surgery is the first listed.
NCT03711890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03711890 about?
NCT03711890 is a clinical study titled "Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer". This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pa...
What is the current status of trial NCT03711890?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2019-03-26. Estimated completion is 2026-09-15.
What interventions are being tested in trial NCT03711890?
The interventions under investigation include: Therapeutic Conventional Surgery (PROCEDURE), Optical Coherence Tomography (PROCEDURE), Laboratory Evaluation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03711890?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.